Dermira

DERM NASDAQ
8.23
+0.32
+4.05%
盘后: 8.23 0 0.00% 17:00 08/16 EDT
开盘
7.92
昨收
7.91
最高
8.42
最低
7.85
成交量
44.91万
成交均量(3M)
67.52万
52周最高
15.48
52周最低
6.00
换手率
0.83%
市值
4.48亿
分时
5日
1月
3月
1年
5年

相关股票

微牛行情栏目提供Dermira DERM股票价格,Dermira股票实时行情,公司简介,财报信息,股本结构等,掌握美港股行情走势,开盘价,收盘价,总市值,换手率,市盈率,收益率等数据,及时把握美股港股投资机会。

公司介绍

Dermira, Inc. is a biopharmaceutical company. The Company is focused on the development of therapeutic solutions in medical dermatology to treat skin conditions, such as hyperhidrosis, psoriasis and acne. Its portfolio includes three late-stage product candidates: Cimzia (certolizumab pegol), glycopyrronium tosylate and olumacostat glasaretil. Cimzia is an injectable biologic tumor necrosis factor-alpha inhibitor, or TNF inhibitor that is approved and marketed for the treatment of numerous inflammatory diseases spanning multiple medical specialties, including rheumatoid arthritis, psoriatic arthritis, ankylosing spondylitis and Crohn's disease, in multiple countries, including the United States. Glycopyrronium tosylate is a small molecule anticholinergic product for topical application for the treatment of primary axillary hyperhidrosis. Olumacostat glasaretil is a small molecule that targets sebum production following topical application for the treatment of acne.
展开 >

最近浏览

名称
价格
涨跌幅